One of Britain’s central think tanks for drug policy reform is looking for new partners to join forces in 2026.
Psilocybin continues to gain momentum as a possible alternative to mental health treatments that leave large numbers of patients without recovery.
Dr. Celia Morgan is one of the UK’s leading figures in ketamine and psychedelic research, especially in the domain of addiction and mental health.
Professor David Nutt stands out as a leading figure in modern psychedelic science, tirelessly pushing the boundaries of how drugs such as psilocybin, MDMA, LSD, DMT,...
Psyched Wellness CEO Jeff Stevens speaks to Psychedelic Health about how the company has launched the first legal Amanita muscaria extract available for sale in the United States.
Awakn CEO, Anthony Tennyson, spoke to Psychedelic Health about the company’s plans to make ketamine therapy accessible to US patients.
Heroic Hearts UK CEO Keith Abraham discusses his journey to setting up the organisation which aims to help veterans living with PTSD.
Psychiatrist Dr Tiago Reis Marques discusses what new research findings on ketamine mean for treatment-resistant mental conditions such as major depressive disorder.
